The present TCGA-based analysis showed that GLUT1 was prominently expressed in CRC, and high level of GLUT1 contribute to poor disease-free survival (DFS) in CRC, but had no significant effect on overall survival (OS) (Figure S4). Here, SLC2A1 is linked to colorectal carcinoma.